CTRI/2015/11/006353招募中4 期
Evaluation of the Safety and Effectiveness of BOTOX® (Botulinum Toxin Type A) in theTreatment of Patients with Urinary Incontinence due to Neurogenic DetrusorOveractivity or Overactive Bladder: A Phase IV Non-interventional Post-marketingSurveillance Study in India
Allergan Healthcare India Pvt Ltd0 个研究点目标入组 250 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •Patients with urinary incontinence (due to NDO, eg, as a result of SCI or MS, or due to OAB) who have an inadequate response to or are intolerant of an anticholinergic medication
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 17.0Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-CZAllergan Limited345
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 14.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-GBAllergan Limited345
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceEUCTR2012-003255-11-BEAllergan Limited345
进行中（未招募）
1 期
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 17.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-DEAllergan Limited345
进行中（未招募）
不适用
A Study Evaluating the Efficacy and Safety of BOTOX® and Solifenacin in Patients with Overactive Bladder and Urinary IncontinenceOveractive Bladder and Urinary IncontinenceMedDRA version: 17.1Level: LLTClassification code 10059617Term: Overactive bladderSystem Organ Class: 100000004857EUCTR2012-003255-11-PLAllergan Limited345